Skip to content
Home/GPs/Azulis Capital
Azulis Capital

Azulis Capital

Paris, France·azulis-capital.com
AUM
€495M
Funds
4
vintages 2004–2021
Portfolio
20
Exits
23

Key facts

HQParis, France

Recent exits

Ital Express (MMF V)
Industrials · 2024 · 5yr hold
Meotec
TMT · 2024 · 6yr hold
Radiologie Paris Ouest
Healthcare · 2024 · 5yr hold
HELIOS
Industrials · 2022 · 3yr hold

Coverage notes

4 funds tracked, 43 portfolio companies (20 active · 23 realized). Verified weekly from public filings and deal announcements.

Funds & portfolio

Every fund Azulis Capital has raised, with its portfolio companies. Hand-checked from public filings.

4 funds
Azulis MMF VIBuyout
2021 · 5yr€280M12 active

Unrealized

12 held
ACENSIActive
TMTFrance· Entry 2025
IndustrialsFrance· Entry 2023
DESTIAActive
HealthcareFrance· Entry 2021
EURADIFActive
IndustrialsFrance· Entry 2022
IndustrialsFrance· Entry 2021
HealthcareFrance· Entry 2026
ConsumerFrance· Entry 2025
ConsumerFrance· Entry 2021
Business ServicesFrance· Entry 2026
NERCOActive
IndustrialsFrance· Entry 2024
ORSYSActive
Business ServicesFrance· Entry 2021
WICHARDActive
IndustrialsFrance· Entry 2023
Azulis MMF VBuyout
2015 · 11yr€215M6 active · 9 realized

Unrealized

6 held
EksaeActive
TMTFrance· Entry 2019
ConsumerFrance· Entry 2019
ConsumerFrance· Entry 2019
JordenenActive
Business ServicesFrance· Entry 2018
ConsumerFrance· Entry 2016
ConsumerFrance· Entry 2019

Realized

9 exits
DESTIA (MMF V)Exited 2021
HealthcareFrance· Entry 2016
HELIOSExited 2022
IndustrialsFrance· Entry 2019
Trade Saleto
IndustrialsFrance· Entry 2019
Secondaryto
Marcel & FilsExited 2021
ConsumerFrance· Entry 2015
Secondaryto
MeotecExited 2024
TMTFrance· Entry 2018
Secondaryto
NovepanExited 2022
ConsumerFrance· Entry 2017
Secondaryto
HealthcareFrance· Entry 2019
Trade Saleto
Business ServicesFrance· Entry 2020
Secondaryto
Vivalto VieExited 2020
HealthcareFrance· Entry 2015
Secondaryto
Azulis MMF IVBuyout
2011 · 15yr€225M1 active · 7 realized

Unrealized

1 held
ConsumerFrance· Entry 2014

Realized

7 exits
BioclinicExited 2018
HealthcareFrance· Entry 2012
Secondaryto
CEMEExited 2022
IndustrialsFrance· Entry 2014
Secondaryto
Holweg WeberExited 2018
IndustrialsFrance· Entry 2012
Secondaryto
Ital ExpressExited 2019
IndustrialsFrance· Entry 2014
Secondaryto
LagarrigueExited 2016
HealthcareFrance· Entry 2011
Secondaryto
LV OverseasExited 2019
IndustrialsFrance· Entry 2013
Secondaryto
SitourExited 2017
Business ServicesFrance· Entry 2011
Secondaryto
Azulis MMF IIIBuyout
2004 · 22yr€109M1 active · 7 realized

Unrealized

1 held
IndustrialsFrance· Entry 2010

Realized

7 exits
IniceaExited 2016
HealthcareFrance· Entry 2010
Secondaryto
ConsumerFrance· Entry 2009
Secondaryto
ConsumerFrance· Entry 2009
Secondaryto
OptimumExited 2015
IndustrialsFrance· Entry 2010
Secondaryto
Prodene KlintExited 2014
ConsumerFrance· Entry 2009
Trade Saleto
IndustrialsFrance· Entry 2009
MBOto
SavenaExited 2011
ConsumerFrance· Entry 2007
Secondaryto
Track Azulis Capital

Saved GPs appear in your watchlist, one click from your workspace.

About Azulis Capital

Azulis Capital is a French mid-market private equity firm with €495 million of assets under management as of December 2024, headquartered in Paris. The firm has built a multi-decade track record across successive flagship vintage funds focused on French mid-cap LBO transactions, with sector breadth across industrials, healthcare, business services and consumer verticals spanning the French mid-market spectrum.

Investment thesis

Azulis targets French mid-cap LBO transactions with equity ticket sizes typically ranging from €10 million to €40 million per transaction, focusing on profitable companies with strong management teams and growth potential. Sector focus spans Industrials, Healthcare, TMT and Business Services, with the firm emphasising operational value creation through management team partnership and selective bolt-on M&A strategies across the holding period.

Recent activity

Recent realised exits include Ital Express (industrials, 2024), Meotec (TMT, 2024), Radiologie Paris Ouest (healthcare, 2024) and CEME (industrials, 2022), reflecting active distribution across multiple sectors. The platform tracks 4 funds, 18 active portfolio companies and 22 realised exits across the multi-vintage French mid-cap programme. Detailed buyer names and multiple data available on Pro at €29/month.

Last updated June 2026 · Sourced from public filings